A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
Status:
Completed
Trial end date:
2013-12-07
Target enrollment:
Participant gender:
Summary
This study is to investigate the efficacy, safety, and plasma concentration change of ASP0456
in patients with constipation-predominant irritable bowel syndrome.